Diabetes

Amring is committed to putting people first in all it does, providing high quality generic medications and excellent customer service at a reasonable cost.

As of 2015, 30.3 million Americans—9.4% of the US population—have diabetes, and another 84.1 million Americans have prediabetes, according to a recently released report from the CDC.

FDA officials noted that the human insulin analog met all necessary regulatory requirements for approval, but the approval is tentative pending any patent issues that are yet to be resolved.

JDRF and IBM partner to develop data-driven methods to predict the onset of type 1 diabetes.

Pancreatic islet cells implanted under the skin may normalize blood glucose levels in type 1 diabetes patients.

Patients who were adherent to oral diabetes drugs spent $500 less on health care compared with nonadherent patients.

Patients who were not adherent to oral diabetes drugs had 1.3 times higher medical costs.

Increasing sleep by a half hour significantly reduced body weight and insulin resistance.

Top news of the day from across the health care landscape.

A look at the top stories in pharmacy last week.

Officials with the FDA have approved a new indication for liraglutide (Victoza, Novo Nordisk).

The CDC gives an overview of several ways patients with diabetes can prevent diabetic foot ulcers and amputations.

Hypoglycemia-related hospitalizations are common among patients with type 2 diabetes.

Walnuts may promote fullness and healthy eating habits.

Prescribing metformin for prediabetes could reduce healthcare costs by $820 million annually.

It may be possible to retrain the immune system to prevent or slow attacks on insulin-producing beta cells.

There are 30 million Americans living with diabetes, and 84 million Americans have prediabetes.

Novel diabetes biosimilar shows similar safety, efficacy, and immunogenicity to the reference drug.

Training the body to recognize beta cells as non-harmful may result in a cure for type 1 diabetes.

A look at the top stories in pharmacy last week.

Top news of the day from across the health care landscape.

New drugs to drive the type 2 diabetes market, but metformin may remain a first-line therapy.

Pharmacists can use innovative approaches to increase the provision of clinical services in medical homes.

The results of a new study published in the Journal of International Medical Research show how pharmacists can use innovative approaches to increase the provision of clinical services in the context of established medical home models.

Transplanting insulin-producing cells under the skin of patients with diabetes shows promise.

Implanted device expected to provide an easy and effective treatment for patients with high-risk type 1 diabetes.

Healthcare providers need to work diligently to lower costs without sacrificing quality to increase value.

Early-term children more likely to develop type 1 diabetes.

Digital and in-person treatment approaches may improve diabetes self-management education and support.

Digital health may help spread diabetes education to patients in underserved or rural areas.